Insider selling is small and routine, no actionable signal. Monitor for any material corporate events (earnings, pipeline updates, M&A) that could trigger more significant insider activity.
ALKS drugs
ALKS drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Jun 5 $42.80entry
- T+1 · 5mo ago −0.82%α −1.04% · $42.45
- T+5 · 5mo ago +3.46%α +2.89% · $44.28
- T+20 · 4mo ago +28.83%α +26.97% · $55.14
- T+60 · 3mo ago +9.79%α +5.79% · $46.99
Price Chart
How similar events traded
Executive Summary
Three Alkermes insiders, including the EVP R&D/CMO and VP Finance, sold a total of ~$1.15M in open-market sales over a 7-day window. The sales are modest relative to the $7.1B market cap (~0.016%) and include derivative exercises that likely generated shares for sale. No insider buying occurred. The cluster is small in dollar terms and likely reflects routine portfolio diversification and tax-related selling rather than a coordinated bearish signal.
Key Financial Metrics
Key Facts
- Total open-market sales: ~$1.15M across 3 insiders
- Sales represent ~0.016% of Alkermes' $7.1B market cap
- EVP R&D/CMO Craig Hopkinson sold 9,000 shares ($375K) after exercising 10,000 options
- VP Finance Samuel Parisi sold 16,217 shares ($687K) after exercising 6,784 options
- EVP/CLO David Gaffin sold 2,034 shares ($88K) with no accompanying derivative exercise
- No insider purchases were reported in the cluster window
Financial Impact
Total insider sales of ~$1.15M, or 0.016% of market cap, immaterial relative to company size
Risk Factors
- Insider sales could accelerate if upcoming pipeline catalysts disappoint
- Derivative exercises may signal insiders locking in gains ahead of volatility
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-ALKS-1780606846664 |
Track record
23 reports on ALKS
3 of 3 bullish or bearish reports moved the stock their way by T+60. Best: +25.88% at T+60 after the May 12, 2026 report. 3 of 4 went positive at some point.
Filters
- Nov 12, 20264d ago 8-K Neutral 4/10 Entry $46.98 Now $46.53 −0.96% settles Feb 10
- Nov 4, 202612d ago Institutional Cluster Neutral 3/10 Entry $44.54 Now $46.53 +4.47% settles Feb 3
- Nov 3, 202613d ago 144 Neutral 2/10 Entry $45.89 Now $46.53 +1.39% settles Feb 2
- Nov 3, 202613d ago 8-K Neutral 5/10 Entry $45.69 Now $46.53 +1.84% settles Feb 1
- Sep 21, 20268w ago 8-K Bullish 6/10 Entry $44.00 Now $46.53 +5.76% settles Dec 15
- Sep 16, 20268w ago 8-K Neutral 2/10 Entry $46.07 Now $46.53 +1.00% settles Dec 10
- Sep 3, 202610w ago Insider Cluster Neutral 2/10 Entry $46.10 Now $46.53 +0.93% settles Dec 1
- Aug 3, 202615w ago Insider Cluster Bearish 4/10 Entry $49.67 to $44.32 Now $46.53 +6.32% ▲ +10.77% +11.15% vs SPY
- Aug 3, 202615w ago Insider Cluster Neutral 2/10 Entry $49.67 to $44.32 Now $46.53 −6.32% ▼ −10.77% −11.15% vs SPY
- Aug 3, 202615w ago Insider Cluster Neutral 3/10 Entry $49.67 to $44.32 Now $46.53 −6.32% ▼ −10.77% −11.15% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers